Auriga International S.A. (Auriga) is a public traded healthcare research company. It is engaged in the research, development, production and sale of dermato-cosmetology products. Its twenty four products are distributed in more than 53 countries world wide. Auriga holds patents for Vitamin C for dermatological applications, Silicone and Vitamin K Oxide. Its products are used to treat the problems of anti ageing, dark circles, cellulite, depigmenting, pre and menopausal skin etc. Its research and development department works in collaboration with Belgian universities, for developing specific patented products for the treatment of various skin tumours and post-surgical treatment in dermatology, plastic surgery and aesthetic medicine. Auriga exports its products mainly to Italy, Poland, France, Russia, Spain, Korea, Maghreb countries, UAE, Philippines. The company is headquartered at Waterloo, Belgium.

Street: 
32, Avenue Victor Hugo
City: 
Braine-l Alleud
Postcode: 
1420
Federal State : 
Belgium
WebSite: 
www.auriga-int.com
Fax: 
32-2-3841397

Company Index Score

Current Index Score Historical Index Score
  • Auriga International SA currently scores 50 % in the index.
  • Auriga International SA is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Auriga International SA is currently ranked 1 out of 4535 companies. This is in the top 0.022 % percent of Pharmaceutical companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets